Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

The US Department of Justice (DOJ) and the US Drug Enforcement Administration (DEA) have proposed a reduction for controlled substances that may be manufactured in the US in 2019. The proposal decreases manufacturing quotas for six opioids for 2019...

Astellas Pharma has acquired Quethera, a Cambridge, UK-headquartered gene-therapy company focused on developing treatments for ocular disorders, such as glaucoma, in a deal worth up to £85 million ($108 million). Through this transaction, Astellas...

Perrigo has announced plans to separate the company's prescription pharmaceuticals (Rx) business following a strategic portfolio review. The move follows continuing weak performance in the company’s Rx business, which accounted for approximately...

ANI Pharmaceuticals, a Baudette, Minnesota-headquartered specialty pharmaceutical company, has acquired WellSpring Pharma Services, an Oakville, Canada-headquartered contract development and manufacturing organization (CDMO) of drug products, for...

Bayer has agreed to sell its global prescription dermatology unit to LEO Pharma, a Ballerup, Denmark-headquartered specialist in dermatology care. The portfolio to be acquired includes branded topical prescription treatments for acne, fungal skin...

The US Food and Drug Administration (FDA) has awarded a total of $6 million to three universities to study and recommend improvements for continuous manufacturing for drug substances and drug products. The awardees are Rutgers University, The...

Amgen has broken ground for a new biomanufacturing plant that will be constructed at its West Greenwich, Rhode Island campus. The new plant, worth up to $200 million, will manufacture products for the US and global markets. Amgen has labeled the...